Chronic kidney disease, or chronic kidney failure, or CKD for short (from the English chronic kidney disease), is one of the most important age-related diseases in dogs and cats.
According to 2023 studies by the International Renal Interest Society (IRIS), it is assumed that 1 to 3% of all our dogs and cats are affected. Cats are at the upper end of this scale, dogs at the lower end. Many pet owners don’t know their animals are ill, because the disease can progress with almost no symptoms until 60–90% of kidney function is lost.
Chronic kidney disease in dogs and cats – what’s currently changing in treatment
For a long time, CKD was considered a “creeping, inevitable companion of old age” that was often only recognized and treated at a late stage.
The official figures still seem to significantly underestimate the problem. More recent studies show
- that around one in three to four cats over the age of 10 has some form of chronic kidney disease. Depending on the study, figures of 50% of affected cats older than 12 years are also reported.
- In dogs, too, CKD is one of the most common chronic diseases in seniors.
Because the disease is still detected late in a large proportion of animals, many dogs and cats live with CKD for years before it is even diagnosed. A lot of time passes in which you could still have had a major influence on the course and quality of life.
New findings from human and veterinary medicine now show: What matters is early diagnosis, well-thought-out feeding, and looking at the heart, blood pressure, and musculature—not just a single kidney value.
Key building blocks of early diagnosis
Detect earlier: more than “just creatinine”!
In the past, CKD was searched for almost exclusively using classic blood values such as creatinine and urea. Today, diagnosis is much more refined—and earlier.
SDMA – symmetric dimethylarginine
- SDMA is a breakdown product of the amino acid arginine and is excreted mainly via the kidneys.
- It increases in the blood when the kidney’s filtration performance (the so-called glomerular filtration rate) decreases—often earlier than creatinine.
- Advantage: SDMA is less dependent on muscle mass. This is especially important in slim, older cats, because creatinine can look “too good” when there is little musculature.
UPC – urine protein-to-creatinine ratio
- UPC stands for Urine Protein-to-Creatinine Ratio, i.e., the protein-to-creatinine ratio in urine.
- Instead of only checking whether there is protein in the urine, you measure how much there is relative to creatinine. This allows relevant proteinuria (pathologically increased protein loss via the kidneys) to be assessed objectively—regardless of how concentrated the urine is.
- Persistently high proteinuria further damages the kidneys and is an important risk factor for progression and prognosis.
Blood pressure measurement
- Chronic kidney disease is often associated with high blood pressure.
- Persistently elevated blood pressure, in turn, damages the kidneys—but also the heart, eyes, and brain.
- That’s why blood pressure measurement is now part of standard CKD diagnostics—mainly in cats, but also in dogs.
Urinalysis and imaging
- Specific gravity (the kidney’s ability to concentrate), sediment (inflammatory cells, bacteria, crystals) and, if needed, urine culture complete the picture.
- Ultrasound helps assess kidney size and structure and rule out other causes.
IRIS staging – grading severity
- IRIS (International Renal Interest Society) provides a scheme that classifies CKD into stages depending on severity.
- It incorporates, among other things, creatinine, SDMA, proteinuria (UPC), and blood pressure.
- This staging helps tailor therapy in a targeted way to the respective stage.
Feeding: moving away from “as little protein as possible”
In human medicine, there is currently intensive debate about whether strict protein restriction in people with CKD is always sensible—or whether some patient groups may even benefit from a bit more protein to prevent muscle loss.
You can’t transfer these findings 1:1 to dogs and cats, but the trend here is also moving away from black-and-white thinking:
Early stages: quality over radical reduction
- In early stages (early IRIS stage 1–2 without marked proteinuria), a strict protein cut is usually not necessary.
- What matters more is:
- high-quality protein in sufficient amounts,
- consistent phosphorus reduction,
- adequate energy intake,
- and a diet that relieves the kidneys without “wasting away” the body.
Advanced stages: moderate protein reduction, no starvation diet
- In later stages (higher IRIS stages, significant proteinuria, pronounced azotemia), classic renal diets are used:
- protein moderately reduced,
- phosphorus significantly reduced,
- adjusted sodium and often added omega-3 fatty acids.
- The goal is to reduce the toxin burden without pushing the body into a protein-energy wasting state—i.e., without loss of muscle and body substance.
MCS – keeping an eye on muscle condition
This is where MCS comes in—the Muscle Condition Score:
- The Muscle Condition Score is a standardized assessment of muscle mass, independent of body fat.
- In addition, there is the BCS (Body Condition Score), which assesses fat tissue.
- Especially in older CKD patients, it’s possible that the dog or cat still looks “normal” or even a bit chubby, but is losing a lot of muscle.
That’s why today the rule is:
Renal diet—yes, but only as strict as muscle condition and stage allow.
Regular monitoring of weight, Body Condition Score, and Muscle Condition Score is now a fixed part of modern CKD therapy.
Heart and kidneys: a sensitive interplay
It’s also becoming increasingly clear that CKD is not just a “kidney problem”, but is closely linked to cardiovascular risk:
- Many CKD patients develop high blood pressure, which in turn strains the heart and further damages the kidneys.
- This can lead to thickening of the heart muscle and structural changes.
- Conversely, heart disease and corresponding therapies (e.g., diuretics) can easily worsen kidney function if you don’t monitor closely.
RAAS blockade – protection for heart and kidneys
The so-called RAAS blockade plays an important role here.
RAAS stands for the renin–angiotensin–aldosterone system—a hormone system that regulates blood pressure and salt and water balance.
In CKD and in heart problems, this system is often overactive:
- Blood vessels constrict,
- blood pressure rises,
- and the kidneys are additionally damaged over time.
Medication is used to “slow down” this system:
- ACE inhibitor (Angiotensin-Converting-Enzyme inhibitor, e.g., benazepril or enalapril)
- or angiotensin II receptor blockers (also called AT1 blockers, e.g., telmisartan, brand name Semintra®).
Goals of RAAS blockade:
- lower blood pressure,
- reduce proteinuria,
- relieve the kidneys and heart in the long term.
This requires careful monitoring of kidney values, electrolytes (e.g., potassium), and blood pressure—especially after starting these medications or changing the dose.
Modern CKD therapy is a modular system
Treatment of CKD in dogs and cats now consists of several building blocks that are combined depending on the stage:
- Adjusted diet
- High-quality, needs-based protein
- Phosphorus reduction; if needed, phosphate binders if blood phosphate remains too high
- Adequate energy intake to prevent muscle loss
- Monitoring blood pressure and proteinuria
- Regular blood pressure measurement
- RAAS blockade (ACE inhibitor or angiotensin II receptor blocker), if needed
- Monitoring the UPC value in urine to assess success
- Symptomatic support
- Medication for Nausea, Vomiting, and loss of appetite
- Treatment of anemia, if pronounced and feasible
- Fluid therapy (infusions or, in cats, if needed, subcutaneous fluids if the heart and circulation tolerate it)
- Regular check-ups
- Blood values (creatinine, urea, SDMA, electrolytes, phosphate)
- Urine (specific gravity, sediment, UPC)
- Blood pressure
- Body Condition Score and Muscle Condition Score
- If needed, cardiac ultrasound and cardiac biomarkers such as NT-proBNP or cardiac troponin I in special cases
What does this mean for pet owners?
The most important “news” in CKD treatment may be this:
The earlier we take a closer look, the more we can do.
For owners, that means very specifically:
- Senior check at the vet from around 7–8 years (often useful earlier in cats):
- blood test including SDMA,
- urine test including UPC,
- blood pressure measurement.
- Take it seriously early if your dog or cat:
- drinks and urinates more,
- slowly loses Weight loss,
- eats worse or becomes pickier with food,
- seems “just old and quieter”.
- With diagnosed CKD:
- consistently controlled feeding (renal diet appropriate to the stage),
- willingness to do regular check-ups,
- careful observation of appetite, drinking behavior, weight, and general condition.
The good news is:
With modern diagnostics, individually tailored nutrition, careful blood pressure and cardiovascular monitoring, and an eye on muscle mass, the quality of life of dogs and cats with CKD can now often be kept stable for many months to years. That is significantly better than what was possible just a few years ago.
Frequently asked questions about kidney failure in dogs and cats (FAQs)
- What is chronic kidney disease (CKD) in dogs and cats?
CKD stands for chronic kidney disease, i.e., chronic kidney disease. The kidneys gradually and permanently lose function over time—and unfortunately, that can’t be reversed. The disease progresses slowly over months to years and is classified into severity grades (so-called IRIS stages). The goal of treatment is to slow progression and maintain quality of life for as long as possible.
- How do I, as an owner, recognize that my pet has CKD?
The first signs are often very non-specific: the animal drinks more, urinates more often, slowly loses weight, eats worse, or simply seems “older” and quieter. These changes are often initially dismissed as normal aging. Clear symptoms such as severe Weight loss, Vomiting, bad breath, or apathy usually only appear in later stages.
- Why is CKD so often only discovered late?
Because the kidneys have a large reserve capacity. An animal can already have lost a significant part of its kidney function before you notice anything from the outside. In addition, classic blood values such as creatinine only rise once there is already a relevant loss of function. That’s why regular senior checks with blood and urine tests are so important—even if the animal seems healthy.
- Which tests are part of modern CKD diagnostics today?
In addition to the general clinical examination, these usually include:
- blood test incl. creatinine, urea, and SDMA (symmetric dimethylarginine, an early marker for the kidney’s filtration performance),
- urine test incl. specific gravity, sediment, and UPC (urine protein-to-creatinine ratio, measures pathological protein loss in urine),
- blood pressure measurement,
- depending on the case, ultrasound of the kidneys.
Based on these data, the disease is classified according to IRIS stages (international kidney staging system).
- What are SDMA and UPC—and why are they important?
SDMA (symmetric dimethylarginine) is a metabolic product that is excreted almost exclusively via the kidneys. If SDMA increases in the blood, it indicates reduced kidney filtration performance—often earlier than creatinine.
UPC (Urine Protein-to-Creatinine Ratio) is the urine protein-to-creatinine ratio. It shows whether the kidneys are losing pathologically high amounts of protein (proteinuria)—an important factor for risk assessment and therapy planning.
- What do the IRIS stages mean in CKD?
IRIS (International Renal Interest Society) classifies CKD in dogs and cats into stages, roughly from 1 (mild, early) to 4 (severe). The basis is primarily creatinine and SDMA values; proteinuria (UPC) and blood pressure are also taken into account. The stage helps the veterinarian classify the disease and adapt treatment (e.g., diet, medication, check-ups) to the severity.
- What role does nutrition play in CKD—does my pet need a renal diet right away?
Nutrition is a central building block of CKD treatment. In early stages, a “classic” renal diet is not always needed immediately, but attention is paid to appropriate amounts of protein in good quality and, above all, reduced phosphorus content. In advanced stages, special renal diets are useful: they relieve the kidneys through moderately reduced protein, significantly less phosphorus, and an adjusted energy and nutrient composition.
- Is there a risk that my pet will lose muscle on a renal diet?
Yes, that can happen if the diet is too strict or the animal takes in too little energy overall. That’s why we don’t just look at weight, but also at the Muscle Condition Score (MCS)—an assessment of muscle mass independent of body fat. If muscle is lost on a renal diet, feeding can be adjusted (e.g., different diet, additional energy, possibly more high-quality protein) to keep the kidneys and musculature as well balanced as possible.
- What does CKD have to do with high blood pressure, the heart, and RAAS blockade?
In CKD, blood pressure is often elevated because the RAAS (renin–angiotensin–aldosterone system) is overactive. This hormone system regulates blood pressure and water/salt balance. Persistent high blood pressure damages both the kidneys and the heart, eyes, and brain.
RAAS blockade refers to medications such as ACE inhibitor (e.g., benazepril) or angiotensin receptor blockers (e.g., telmisartan, Semintra) that slow down this system. This can lower blood pressure and protein loss in urine—an important protection for the kidneys and heart.
- What is the prognosis—can my pet still live well for a long time with CKD?
The prognosis depends strongly on the stage, the animal’s overall condition, and how consistently therapy is implemented. Many dogs and cats can live with CKD—with good quality of life for a long time, especially if it is detected early. Regular check-ups (blood, urine, blood pressure), appropriate nutrition, and early adjustment of therapy as soon as values or well-being change are crucial. As an owner, you can contribute a great deal to success through attentive observation and good cooperation with your veterinary practice.
Literature sources
- Feline CKD guideline
Sparkes, A. H., Caney, S., Chalhoub, S., Elliott, J., Finch, N., Gajanayake, I., Langston, C., Lefebvre, H. P., White, J., & Quimby, J. (2016). ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. Journal of Feline Medicine and Surgery, 18(3), 219–239. https://doi.org/10.1177/1098612X16631234
- Nutritional management for dogs/cats with CKD
Parker, V. J. (2021). Nutritional management for dogs and cats with chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice, 51(3), 685–710. https://doi.org/10.1016/j.cvsm.2021.01.007
- Renal diet in cats (prospective RCT)
Ross, S. J., Osborne, C. A., Kirk, C. A., Lowry, S. R., Koehler, L. A., & Polzin, D. J. (2006). Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. Journal of the American Veterinary Medical Association, 229(6), 949–957. https://doi.org/10.2460/javma.229.6.949 PubMed+1
- Renal diet in dogs (prospective RCT)
Jacob, F., Polzin, D. J., Osborne, C. A., Allen, T. A., Kirk, C. A., Neaton, J. D., Lekcharoensuk, C., & Swanson, L. L. (2002). Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. Journal of the American Veterinary Medical Association, 220(8), 1163–1170. https://doi.org/10.2460/javma.2002.220.1163 PubMed+1
- SDMA as a biomarker – dogs with naturally occurring CKD
Hall, J. A., Yerramilli, M., Obare, E., Yerramilli, M., Almes, K., & Jewell, D. E. (2016). Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease. Journal of Veterinary Internal Medicine, 30(3), 794–802. https://doi.org/10.1111/jvim.13942 PubMed+1
- SDMA overview/review (small animals)
Relford, R., Robertson, J., & Clements, C. (2016). Symmetric dimethylarginine: Improving the diagnosis and staging of chronic kidney disease in small animals. Veterinary Clinics of North America: Small Animal Practice, 46(6), 941–960. https://doi.org/10.1016/j.cvsm.2016.06.010 PubMed+1
- Telmisartan vs. benazepril (RAAS blockade, proteinuric cats)
Sent, U., Gössl, R., Elliott, J., Syme, H. M., & Zimmering, T. (2015). Comparison of efficacy of long-term oral treatment with telmisartan and benazepril in cats with chronic kidney disease. Journal of Veterinary Internal Medicine, 29(6), 1479–1487. https://doi.org/10.1111/jvim.13639 PubMed+1
- CvRD / cardiovascular-renal axis (dog/cat)
Pouchelon, J. L., Atkins, C. E., Bussadori, C., Oyama, M. A., Vaden, S. L., Bonagura, J. D., Chetboul, V., Cowgill, L. D., Elliott, J., Francey, T., Grauer, G. F., Luis Fuentes, V., Moise, N. S., Polzin, D. J., Van Dongen, A. M., & Van Israël, N. (2015). Cardiovascular-renal axis disorders in the domestic dog and cat: A veterinary consensus statement. Journal of Small Animal Practice, 56(9), 537–552. https://doi.org/10.1111/jsap.12387 PubMed+1
- IRIS staging (CKD classification in dogs/cats)
International Renal Interest Society. (n.d.). IRIS staging of chronic kidney disease in dogs and cats. IRIS. Retrieved 7 December 2025, from https://www.iris-kidney.com/iris-staging-system ResearchGate+1